Loading chat...
US HB3239
Bill
Status
5/7/2025
Primary Sponsor
Chrissy Houlahan
Click for details
AI Summary
-
Requires SBIR and STTR program peer reviews to evaluate commercialization likelihood alongside scientific merit, with at least one reviewer having commercialization expertise
-
Reduces the timeline for certain program requirements from 1 year to 180 days and expands phase flexibility authority to all federal agencies with SBIR/STTR programs through fiscal year 2027, with spending caps of 10% (30% for NIH, unlimited for DOD)
-
Mandates each participating federal agency designate a Technology Commercialization Official to guide awardees, advocate for promising technologies, and coordinate cross-agency commercialization pathways
-
Increases technical and business assistance funding caps to $6,500 for Phase I and $50,000 for Phase II awards, adds cybersecurity assistance as an allowable expense, and requires agencies to offer I-Corps participation options
-
Creates a commercialization impact assessment requiring annual reporting on companies with 50+ Phase II awards, tracking metrics including revenue, patents, investment, acquisitions, and Phase III contracts over 9-year periods
Legislative Description
Research Advancing to Market Production for Innovators Act
Commerce
Last Action
Referred to the Committee on Small Business, and in addition to the Committees on Science, Space, and Technology, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
5/7/2025